The cutting edge

Although critical illness insurance (CI) is a simple product in theory, some highly complex issues are starting to emerge, particularly in the UK, stemming largely from the potential financial impact of medical advances. Such advances are largely beyond the control of the insurance industry, but they need to be kept abreast of and factored into any long-term pricing decisions.

The product is currently profitable in the UK, but there are concerns regarding the robustness of definitions against

To continue reading...

You must be signed in to use this feature.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: